A secondary analysis of the phase 2 PACIFIC-STROKE trial showed that asundexian is effective for the secondary prevention of stroke in patients with stroke of atherosclerotic origin, but not those ...
There was no significant difference in functional dependency or death at 90 days between patients with single subcortical infarction only who received early vs delayed antihypertensive treatment.
The research team of Prof.Sung Hoon Kang and Chi Kyung Kim of the Department of Neurology and Prof.Jae Seon Eo of the Department of Nuclear Medicine, Korea University’s Guro Hospital, confirmed that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback